Eledon Pharmaceuticals, Inc. (ELDN): Operating Cash Flow
-$62.34M
Year ended 2025-12-31
-$73.86M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$62.34M | n/m | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | -$47.27M | n/m | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | -$39.53M | n/m | 2025-08-14, From 2023-01-01 |
| 2022-12-31 | -$28.42M | n/m | 2024-08-19, From 2022-01-01 |
| 2021-12-31 | -$28.91M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$15.21M | n/m | 2022-03-24, From 2020-01-01 |
| 2019-12-31 | -$13.86M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$11.89M | n/m | 2020-03-17, From 2018-01-01 |
| 2017-12-31 | -$14.94M | n/m | 2019-03-28, From 2017-01-01 |
| 2016-12-31 | -$4.92M | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$41.24M | n/m | 2017-03-03, From 2015-01-01 |
| 2014-12-31 | -$21.12M | n/m | 2017-03-03, From 2014-01-01 |
| 2013-12-31 | -$15.48M | n/m | 2016-03-10, From 2013-01-01 |
| 2012-12-31 | -$9.33M | n/a | 2015-03-26, From 2012-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | -$62.34M | n/m |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | -$64.49M | n/m |
| Climb Bio, Inc. (CLYM) | 2025-12-31 | -$54.36M | n/m |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $1.01M | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$171.27M | n/m |
| PepGen Inc. (PEPG) | 2025-12-31 | -$81.64M | n/m |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | -$8.93M | n/m |
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | -$43.90M | n/m |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | -$19.52M | n/m |
Compare ELDN, CRBP, CLYM, GYRE side by side · Screen every company in Pharmaceutical Preparations ↗